Urine spermine and multivariable Spermine Risk Score predict high-grade prostate cancer

被引：0
|
作者：
Peter Ka-Fung Chiu
Yan-Ho Fung
Jeremy Yuen-Chun Teoh
Chun-Hong Chan
Ka-Lun Lo
Kai-Man Li
Ryan Tsz-Hei Tse
Chi-Ho Leung
Yim-Ping Wong
Monique J. Roobol
Ka-Leung Wong
Chi-Fai Ng
机构：
[1] The Chinese University of Hong Kong,SH Ho Urology Centre, Division of Urology, Department of Surgery
[2] Hong Kong Baptist University,Department of Chemistry
[3] North District Hospital,Division of Urology, Department of Surgery
[4] Erasmus MC,Department of Urology
来源：
Prostate Cancer and Prostatic Diseases | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：542 / 548
页数：6
相关论文
共 50 条
  • [31] IDENTIFICATION OF HIGH-GRADE PROSTATE CANCER USING URINE-BASED MOLECULAR BIOMARKERS COMBINED WITH CLINICAL RISK FACTORS
    Van Neste, Leander
    Trooskens, Geert
    Hendriks, Rianne J.
    Schalken, Jack
    Van Criekinge, Wim
    JOURNAL OF UROLOGY, 2016, 195 (04): : E698 - E698
  • [32] A gene expression signature to predict high-grade prostate cancer response to oxaliplatin.
    Pourquier, Philippe
    Puyo, Stephane
    Richaud, Pierre
    Robert, Jacques
    Houede, Nadine
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [33] Radical prostatectomy for high-grade prostate cancer
    Hurwitz, Mark D.
    Schultz, Delray
    Richie, Jerome P.
    Wein, Alan J.
    Whittington, Richard
    Malkowicz, S. Bruce
    D'Amico, Anthony V.
    UROLOGY, 2006, 68 (02) : 367 - 370
  • [34] Finasteride and High-Grade Prostate Cancer Response
    Redman, Mary M.
    Tangen, Catherine M.
    Goodman, Phyllis J.
    Thompson, Ian M.
    CANCER PREVENTION RESEARCH, 2009, 2 (02)
  • [35] MyProstateScore for Predicting High-Grade Prostate Cancer
    Balloga, Sarah M.
    Chang, Jennifer G.
    AMERICAN FAMILY PHYSICIAN, 2022, 105 (05) : 542 - 543
  • [36] Antioxidant and Vitamin E Transport Genes and Risk of High-Grade Prostate Cancer and Prostate Cancer Recurrence
    Bauer, Scott R.
    Richman, Erin L.
    Sosa, Eduardo
    Weinberg, Vivian
    Song, Xiaoling
    Witte, John S.
    Carroll, Peter R.
    Chan, June M.
    PROSTATE, 2013, 73 (16): : 1786 - 1795
  • [37] STATIN USE OF THE RISK OF PROSTATE CANCER AND HIGH-GRADE PROSTATE CANCER: RESULTS FROM THE REDUCE STUDY
    Freedland, Stephen
    Gerber, Leah
    Banez, Lionel
    Moreira, Daniel
    Andriole, Gerald
    Rittmaster, Roger
    JOURNAL OF UROLOGY, 2011, 185 (04): : E135 - E135
  • [38] Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study
    Freedland, S. J.
    Hamilton, R. J.
    Gerber, L.
    Banez, L. L.
    Moreira, D. M.
    Andriole, G. L.
    Rittmaster, R. S.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (03) : 254 - 259
  • [39] Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study
    S J Freedland
    R J Hamilton
    L Gerber
    L L Banez
    D M Moreira
    G L Andriole
    R S Rittmaster
    Prostate Cancer and Prostatic Diseases, 2013, 16 : 254 - 259
  • [40] Finasteride and high-grade prostate cancer in the prostate cancer prevention trial
    Lucia, M. Scott
    Epstein, Jonathan I.
    Goodman, Phyllis J.
    Darke, Amy K.
    Reuter, Victor E.
    Civantos, Francisco
    Tangen, Catherine M.
    Parnes, Howard L.
    Lippman, Scott M.
    La Rosa, Francisco G.
    Kattan, Michael W.
    Crawford, E. David
    Ford, Leslie G.
    Coltman, Charles A., Jr.
    Thompson, Ian M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (18): : 1375 - 1383
12345